Eliem Therapeutics, Inc. (ELYM) Social Stream



Eliem Therapeutics, Inc. (ELYM): $7.41

0.03 (-0.40%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ELYM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#46 of 360

in industry

ELIEM THERAPEUTICS INC (ELYM) Price Targets From Analysts

Use the tables below to see what analysts covering ELIEM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-21 3 $35 $32 $33.333 $2.73 1120.99%
2022-05-16 3 $35 $13 $26.666 $2.73 876.78%
2022-07-21 3 $35 $9 $25.333 $2.73 827.95%
2022-08-02 3 $32 $8 $16.333 $2.73 498.28%
2022-08-16 3 $32 $4 $14.666 $2.73 437.22%
2023-01-23 4 $8 $4 $6 $2.73 119.78%
2023-03-08 1 $6 $6 $6 $2.73 119.78%
2023-04-20 4 $8 $4 $6 $2.73 119.78%
2023-05-12 3 $8 $4 $6 $2.73 119.78%
2023-05-16 3 $6 $4 $5 $2.73 83.15%

The Trend in the Analyst Price Target


ELYM's average price target has moved down $28.33 over the prior 20 months.

ELYM reports an average of 73.43% for its upside potential over the past 113 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-23 4 8 4 6 3.995 50.19%
2023-03-08 4 8 4 6 3.640 64.84%
2023-03-08 1 8 4 6 3.640 64.84%
2023-03-08 4 6 6 6 3.640 64.84%
2023-05-12 3 8 4 6 3.200 87.5%

ELYM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


ELYM's average broker recommendation rating worsened by 0.42 over the prior 19 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ELYM as an investment opportunity.

  • ELYM has a greater number of analysts covering the stock than 65.1% of all US stocks.
  • In terms of how ELIEM THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 806.96% of that group.
  • In the context of all US stocks, ELIEM THERAPEUTICS INC's variance in analysts' estimates is lower than -467.87% of them.
  • ELIEM THERAPEUTICS INC's average analyst price target is higher than 346.31% of stocks in the small market cap category.

In the Pharmaceutical Products industry, TYRA, THRX, and PYXS are the three stocks most similar to ELIEM THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is ELYM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!